Core Scientific
- Market cap
- 5.12B
- P/E (TTM)i
- -3.16
- P/Bi
- -2.12
- EPSi
- -0.88
- Div yieldi
- 0.00%
- 52W posi
- 15%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions decreased by 1 in the most recent period (2026/Q3).
- Total institutional ownership fell 2.0 percentage points.
Institutional ownership
- Held by institutions
- 117.55% -2.03pp
- Institutions
- 491 -1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Top holders as of 2026-06-30
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 9 buys · 40 sells
| Name | Role | Stake |
|---|---|---|
| Adam Sullivan | Chief Executive Officer | 0.76% |
| Todd Duchene | Chief Legal Officer & Chief Administrative Officer | 0.59% |
| James Nygaard | Chief Financial Officer | 0.12% |
| Denise Sterling | Chief Financial Officer | 0.11% |
| Jordan Levy | Independent Director | 0.06% |
| Eric Weiss | Independent Director | 0.04% |
| Yadin Rozov | Independent Director | 0.03% |
| Jeff Booth | Independent Director | 0.02% |
| Elizabeth Crain | Director | 0.00% |
| Mark Adams | Director | -- |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-30 | Todd Duchene | Chief Legal Officer & Chief Administrative Officer | Sale to Issuer | -8,228 | $15.98 |
| 2026-09-30 | Adam Sullivan | Chief Executive Officer | Sale to Issuer | -23,508 | $15.98 |
| 2026-09-27 | Todd Duchene | Chief Legal Officer & Chief Administrative Officer | Automatic Disposition | -10,000 | $16.76 |
| 2026-09-20 | Todd Duchene | Chief Legal Officer & Chief Administrative Officer | Automatic Disposition | -10,000 | $18.37 |
| 2026-09-14 | Eric Weiss | Independent Director | Open Market Acquisition | +6,000 | $16.33 |
| 2026-09-13 | Todd Duchene | Chief Legal Officer & Chief Administrative Officer | Automatic Disposition | -10,000 | $17.14 |
| 2026-09-08 | Todd Duchene | Chief Legal Officer & Chief Administrative Officer | Other Derivative Disposition | -95,000 | $6.81 |
| 2026-09-07 | Todd Duchene | Chief Legal Officer & Chief Administrative Officer | Automatic Disposition | -10,000 | $18.67 |
| 2026-08-30 | Todd Duchene | Chief Legal Officer & Chief Administrative Officer | Automatic Disposition | -10,000 | $16.23 |
| 2026-08-23 | Todd Duchene | Chief Legal Officer & Chief Administrative Officer | Automatic Disposition | -10,000 | $17.45 |
| 2026-08-19 | Elizabeth Crain | Director | Open Market Acquisition | +6,000 | $18.33 |
| 2026-08-17 | Eric Weiss | Independent Director | Open Market Acquisition | +7,000 | $19.19 |
| 2026-08-16 | Todd Duchene | Chief Legal Officer & Chief Administrative Officer | Sale to Issuer | -11,205 | $20.13 |
| 2026-08-16 | Todd Duchene | Chief Legal Officer & Chief Administrative Officer | Automatic Disposition | -10,000 | $20.10 |
| 2026-08-09 | Todd Duchene | Chief Legal Officer & Chief Administrative Officer | Automatic Disposition | -10,000 | $19.90–20.65 |
| 2026-08-02 | Todd Duchene | Chief Legal Officer & Chief Administrative Officer | Automatic Disposition | -10,000 | $20.39–22.62 |
| 2026-07-29 | Mark Adams | Director | Other Acquisition | +27,594 | -- |
| 2026-07-26 | Todd Duchene | Chief Legal Officer & Chief Administrative Officer | Automatic Disposition | -10,000 | $20.75–22.49 |
| 2026-07-19 | Todd Duchene | Chief Legal Officer & Chief Administrative Officer | Automatic Disposition | -10,000 | $22.30 |
| 2026-07-15 | Todd Duchene | Chief Legal Officer & Chief Administrative Officer | Sale to Issuer | -4,325 | $22.72 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 08:22:25 · For reference only, not investment advice and not tailored to your situation.